Researcher Profile

Researcher Profile

Andry Van De Louw, MD, PhD

Andry Van De Louw, MD, PhD

Associate Professor, Department of Medicine
Division of Pulmonary, Allergy and Critical Care Medicine
Scientific Program:Cancer Control
axv19@psu.edu

Research Interests

  • Respiratory Insufficiency
  • Acute Myeloid Leukemia
  • Respiration
  • Mortality
  • Critical Illness
  • Artificial Respiration
  • Oxygen
  • Intensive Care Units
  • Lung
  • Hemorrhage
  • Hemorrhagic Shock
  • Heart Rate

Recent Publications

2019

Martin-Loeches, I, Lemiale, V, Geoghegan, P, McMahon, MA, Pickkers, P, Soares, M, Perner, A, Meyhoff, TS, Bukan, RB, Rello, J, Bauer, PR, Van De Louw, A, Taccone, FS, Salluh, J, Hemelaar, P, Schellongowski, P, Rusinova, K, Terzi, N, Mehta, S, Antonelli, M, Kouatchet, A, Klepstad, P, Valkonen, M, Landburg, PP, Barratt-Due, A, Bruneel, F, Pène, F, Metaxa, V, Moreau, AS, Souppart, V, Burghi, G, Girault, C, Silva, UVA, Montini, L, Barbier, F, Nielsen, LB, Gaborit, B, Mokart, D, Chevret, S & Azoulay, E 2019, 'Influenza and associated co-infections in critically ill immunosuppressed patients' Critical Care, vol. 23, no. 1, 152. https://doi.org/10.1186/s13054-019-2425-6
Groupe de Recherche en Reanimation Respiratoire du patient d’Onco-Hématologie (Grrr-OH) 2019, 'Severe toxicity from checkpoint protein inhibitors: What intensive care physicians need to know?' Annals of Intensive Care, vol. 9, no. 1, 25. https://doi.org/10.1186/s13613-019-0487-x

2018

Van De Louw, A, Lewis, AM & Yang, Z 2019, 'Autopsy findings in patients with acute myeloid leukemia and non-Hodgkin lymphoma in the modern era: a focus on lung pathology and acute respiratory failure', Annals of Hematology, vol. 98, no. 1, pp. 119-129. https://doi.org/10.1007/s00277-018-3494-3
Van De Louw, A, Desai, RJ, Zhu, J & Claxton, D 2018, 'Characteristics of early acute respiratory distress syndrome in newly diagnosed acute myeloid leukemia', Leukemia and Lymphoma, vol. 59, no. 10, pp. 2369-2376. https://doi.org/10.1080/10428194.2018.1435874
Keefer, K, Bender, R, Liao, JJ, Sivik, J & Van De Louw, A 2018, 'Characteristics of pulmonary complications in non-Hodgkin’s lymphoma patients treated with rituximab-containing chemotherapy and impact on survival' Annals of Hematology, vol. 97, no. 12, pp. 2373-2380. https://doi.org/10.1007/s00277-018-3448-9
Fitzpatrick, N, Guck, D & Van De Louw, A 2018, 'Impact of Rothman index on delay of ICU transfer for hematology and oncology patients deteriorating in wards' Critical care (London, England), vol. 22, no. 1. https://doi.org/10.1186/s13054-018-2268-6
Carr, Z, Van De Louw, A, Fehr, G, Li, JD, Kunselman, A & Ruiz-Velasco, V 2018, 'Increased whole blood FFA2/GPR43 receptor expression is associated with increased 30-day survival in patients with sepsis' BMC Research Notes, vol. 11, no. 1, 41. https://doi.org/10.1186/s13104-018-3165-4
Domaradzki, L, Gosala, S, Iskandarani, K & Van De Louw, A 2018, 'Is venous blood gas performed in the Emergency Department predictive of outcome during acute on chronic hypercarbic respiratory failure?', Clinical Respiratory Journal, vol. 12, no. 5, pp. 1849-1857. https://doi.org/10.1111/crj.12746

2017

for the Efraim investigators and the Nine-I study group 2017, 'Acute hypoxemic respiratory failure in immunocompromised patients: the Efraim multinational prospective cohort study', Intensive Care Medicine, vol. 43, no. 12, pp. 1808-1819. https://doi.org/10.1007/s00134-017-4947-1
Schneider, C, Bayerl, M, Boyer, C, Desai, R, Claxton, D & Van De Louw, A 2017, 'Increased CD13 expression in acute myeloid leukemia-associated early acute hypoxic respiratory failure', American Journal of Respiratory and Critical Care Medicine, vol. 196, no. 8, pp. 1077-1080. https://doi.org/10.1164/rccm.201701-0080LE

2016

Santos, MA, Spinazzola, J & Van De Louw, A 2016, 'A Silent Relic: Uremic Pericardial Effusion' American Journal of Medicine, vol. 129, no. 10, pp. 1057-1059. https://doi.org/10.1016/j.amjmed.2016.05.043
Stefanski, M, Jamis-Dow, CA, Bayerl, M, Desai, RJ, Claxton, D & Van De Louw, A 2016, 'Chest radiographic and CT findings in hyperleukocytic acute myeloid leukemia A retrospective cohort study of 73 patients', Medicine (United States), vol. 95, no. 44, e5285. https://doi.org/10.1097/MD.0000000000005285
Van De Louw, A 2017, 'Effect of leukapheresis on blood coagulation in patients with hyperleukocytic acute myeloid leukemia', Transfusion and Apheresis Science, vol. 56, no. 2, pp. 214-219. https://doi.org/10.1016/j.transci.2016.12.001
Van De Louw, A, Desai, RJ, Schneider, CW & Claxton, D 2016, 'Hypoxemia during extreme hyperleukocytosis: How spurious?', Respiratory Care, vol. 61, no. 1, pp. 8-14. https://doi.org/10.4187/respcare.04196
Van De Louw, A, Schneider, CW, Desai, RJ & Claxton, D 2016, 'Initial respiratory status in hyperleukocytic acute myeloid leukemia: Prognostic significance and effect of leukapheresis' Leukemia and Lymphoma, vol. 57, no. 6, pp. 1319-1326. https://doi.org/10.3109/10428194.2015.1094695
Bulathsinghala, M, Keefer, K & Van De Louw, A 2016, 'Trimethoprim/Sulfamethoxazole-Induced Severe Lactic Acidosis', Medicine (United States), vol. 95, no. 17, e3478. https://doi.org/10.1097/MD.0000000000003478

2015

Filliau, C, Younes, M, Blanchard, AL, Piscione, J, Van De Louw, A, Seguret, C, Israel, J & Cottin, F 2015, 'Effect of "touch rugby" training on the cardiovascular autonomic control in sedentary subjects' International Journal of Sports Medicine, vol. 36, no. 7, pp. 567-572. https://doi.org/10.1055/s-0034-1398648
Haouzi, P & Van De Louw, A 2015, 'Persistent reduced oxygen requirement following blood transfusion during recovery from hemorrhagic shock', Respiratory Physiology and Neurobiology, vol. 215, pp. 39-46. https://doi.org/10.1016/j.resp.2015.04.009

Clinical Trials Search


Children (age < 18 years)
Adults (age >= 18 years)